June 19, 2019
About 169.1 million doses of the seasonal influenza vaccine were administered last flu season, and about 200 patients received expired vaccines—though the real figure might be higher, according to a CDC report published Friday.
June 18, 2019
CMS Administrator Seema Verma in August 2018 warned HHS Secretary Alex Azar against three policy changes that she estimated would decrease Affordable Care Act exchange enrollment by 1.1 million and jeopardize the exchange market, according to an internal memo.
The number of measles cases reported in the United States this year has continued to grow, and state and local health departments—which are largely responsible for tracking, reporting, and combating measles outbreaks—are feeling strained.
FDA on Thursday warned providers and patients of the potential life-threatening risks of fecal microbiota transplants (FMT), after a patient who received an FMT was infected with a drug-resistant bacteria and died.
June 17, 2019
Three pharmaceutical companies and the Association of National Advertisers on Friday filed a lawsuit challenging HHS' final rule to require drugmakers to disclose their products' list prices in consumer-directed television advertisements, claiming the final rule exceeds HHS' statutory authority and violates the First Amendment of the Constitution.
The median total costs insurers and patients paid for the 49 most popular prescription drugs in the United States, by sales, increased between 2012 and 2017, with many of those costs increasing more than twofold, according to a recent study.
HHS' Office of Inspector General earlier this month issued a fraud alert warning Medicare beneficiaries about an alleged ongoing scam involving genetic testing.
June 14, 2019
The Trump administration on Thursday finalized a rule that will allow U.S. workers to use employer-funded health reimbursement arrangements to purchase private health coverage.
Nursing facilities often fail to report serious cases of potential abuse and neglect of Medicare beneficiaries, according to two new reports from HHS' Office of Inspector General.
CMS on Wednesday approved Washington's plan to negotiate value-based drug agreements with the makers of hepatitis C treatments under a subscription-like model.
Advisory Board. All rights reserved.